ELITE PHARMACEUTICALS INC /NV/
ELTPDrugs in Pipeline
2
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Oxycodone/Naltrexone Capsules | Phase 3 | Withdrawal Symptoms | - | - |
Oxycodone Naltrexone (a) | Phase 3 | Pain | - | - |
Frequently asked questions
What is in ELITE PHARMACEUTICALS INC /NV/'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in ELITE PHARMACEUTICALS INC /NV/'s (ELTP) pipeline across Phase 3. Its lead program is Oxycodone/Naltrexone Capsules (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is ELITE PHARMACEUTICALS INC /NV/'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for ELITE PHARMACEUTICALS INC /NV/ (ELTP) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ELTP biotech catalysts?→
Add ELTP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ELITE PHARMACEUTICALS INC /NV/'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.